Sylvie Bertholet Selected Research

Tetanus Toxoid (Vaccine, Tetanus)

1/2018

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvie Bertholet Research Topics

Disease

11	Infections 01/2016 - 04/2003
8	Human Influenza (Influenza) 01/2016 - 10/2010
6	Tuberculosis (Tuberculoses) 09/2013 - 12/2008
6	Leishmaniasis 11/2012 - 09/2003
3	Visceral Leishmaniasis (Kala Azar) 05/2009 - 04/2003
2	Peritonitis 01/2016 - 01/2015
2	Cutaneous Leishmaniasis 05/2009 - 09/2003
2	Inflammation (Inflammations) 11/2007 - 09/2003
1	Confusion (Bewilderment) 06/2022
1	Diphtheria 01/2018
1	Tetanus 01/2018
1	Whooping Cough (Pertussis) 01/2018
1	Virus Diseases (Viral Diseases) 01/2016
1	Abscess 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Superinfection 01/2016
1	Neutropenia 08/2015
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 08/2014
1	Communicable Diseases (Infectious Diseases) 04/2013
1	Bites and Stings (Sting) 11/2012
1	Vivax Malaria 05/2012
1	Malaria 09/2011
1	Pulmonary Tuberculosis 08/2011
1	Otitis 11/2007
1	Parasitic Diseases (Parasitic Disease) 09/2006
1	Brucellosis (Malta Fever) 02/2004
1	Reinfection 09/2003

Drug/Important Bio-Agent (IBA)

20	VaccinesIBA 01/2018 - 09/2003
12	AntigensIBA 01/2018 - 09/2003
7	Proteins (Proteins, Gene)FDA Link 06/2022 - 12/2008
5	Subunit VaccinesIBA 01/2016 - 12/2008
4	AntibodiesIBA 01/2016 - 09/2011
4	CytokinesIBA 08/2015 - 04/2003
3	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2016 - 01/2015
3	Neuraminidase (Sialidase)IBA 01/2015 - 08/2013
2	Hemagglutinins (Hemagglutinin)IBA 01/2018 - 08/2013
2	Neutralizing AntibodiesIBA 01/2016 - 01/2015
2	MF59 oil emulsionIBA 01/2016 - 01/2015
2	aluminum sulfate (alum)IBA 01/2016 - 01/2015
2	EmulsionsIBA 01/2015 - 05/2009
2	Rifampin (Rifampicin)FDA LinkGeneric 04/2013 - 11/2007
2	PolyproteinsIBA 11/2012 - 10/2010
2	Interferon-gamma (Interferon, gamma)IBA 11/2007 - 09/2003
1	Indicators and Reagents (Reagents)IBA 06/2022
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	Pertussis ToxinIBA 01/2018
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2018
1	pertactin FDA Link 01/2018
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 01/2018
1	mRNA VaccinesIBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Lipid NanoparticlesIBA 01/2016
1	Combined VaccinesIBA 01/2015
1	LectinsIBA 01/2015
1	Immunoglobulin G (IgG)IBA 01/2015
1	EnzymesIBA 01/2015
1	Pattern Recognition ReceptorsIBA 08/2014
1	Immunoglobulin A (IgA)IBA 04/2014
1	Synthetic Vaccines (Recombinant Vaccines)IBA 08/2013
1	Tuberculosis VaccinesIBA 04/2013
1	Isoniazid (Ftivazide)FDA LinkGeneric 04/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2013
1	Leishmaniasis VaccinesIBA 11/2012
1	Malaria VaccinesIBA 09/2011
1	Mycobacterium tuberculosis antigensIBA 08/2011
1	Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA 10/2010
1	Interleukin-2 (IL2)IBA 10/2010
1	monophosphoryl lipid AIBA 05/2009
1	SterolsIBA 10/2007
1	Histocompatibility Antigens Class IIBA 09/2006
1	EpitopesIBA 10/2005
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2004
1	IgE Receptors (Fc epsilon RI)IBA 02/2004
1	CPG-oligonucleotideIBA 09/2003
1	OligodeoxyribonucleotidesIBA 09/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 04/2013 - 08/2011
1	Duration of Therapy 04/2013
1	Therapeutics 08/2011
1	Injections 10/2010
1	Ligation 02/2004